FDA Approved: CABERGOLINE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved Somerset Therapeutics' original application for cabergoline. Cabergoline is a dopamine agonist used to treat hyperprolactinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

ORIG AP for CABERGOLINE (CABERGOLINE)